Metastatic Colorectal Cancer Clinical Trials in Chicago, Illinois

3 studies are recruiting for metastatic colorectal cancer in Chicago, Illinois right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer

    CRC is the third most common type of cancer diagnosed worldwide with developed countries at highest risk. The purpose of this study is to assess adverse events and change in disease activity when telisotuzumab adizutecan is given in combination with oxaliplatin, fluorouracil (5FU), leucovorin (LV) …

    Stage
    Phase 2
    Ages
    18 and older
    Site
    University of Chicago Medical Center /ID# 271688, Chicago, Illinois
    Locations
    71 in total
    Run by
    AbbVie

    See if you can join NCT06820463 on ClinicalTrials.gov

  2. Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation

    The aim of this study is to compare progression free survival (PFS) in treatment-naïve participants with KRAS p.G12C mutated metastatic colorectal cancer (mCRC) receiving sotorasib, panitumumab and FOLFIRI vs FOLFIRI with or without bevacizumab-awwb.

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Insight Research Institute, Chicago, Illinois
    Locations
    291 in total
    Run by
    Amgen

    See if you can join NCT06252649 on ClinicalTrials.gov

  3. A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer

    The main purpose of this study is to evaluate the safety and efficacy of novel study interventions and combinations in participants with Colorectal Cancer (CRC).

    Stage
    Phase 2
    Ages
    18 to 130
    Site
    Research Site, Chicago, Illinois
    Locations
    76 in total
    Run by
    AstraZeneca

    See if you can join NCT06792695 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.